Blocking eosinophil adhesion molecules with RGDS peptide reduces collagen and fibronectin gene activity in airway muscle cells to levels seen with healthy eosinophils.
Scientific Claim
Suppression of eosinophil integrins using RGDS peptide is associated with reduced COL1A1 and fibronectin gene expression in airway smooth muscle cells to levels similar to those seen with healthy eosinophils (p < 0.05).
Original Statement
“Integrins’ suppression only affected asthmatic eosinophils—before and 24 h after bronchial allergen challenge on all four—TGF-β1, WNT-5A, COL1A1, and FN-expression in ASM cells after incubation with eosinophils. Gene expression was significantly downregulated before (accordingly COL1A1 3.15 ± 0.36 vs. 1.78 ± 0.21 folds over control ASM cells, p < 0.05; FN 2.75 ± 0.59 vs. 1.32 ± 0.08 folds over control ASM cells, p < 0.05)”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The study is observational and in vitro, so causal language is inappropriate. 'Associated with' correctly reflects the associative evidence.